Rayence Breaks the Boundaries of Point-of-Care Imaging with the Launch of Integrated Portable X-ray Diagnostic Solutions 'Anywhere-M' and 'Anywhere-V'
South Korean medical imaging firm Rayence has launched new integrated portable X-ray diagnostic solutions, Anywhere-M for human healthcare and Anywhere-V for veterinary applications. These all-in-one systems combine a portable X-ray generator, a digital detector, and proprietary imaging software into a unified workflow, designed to extend high-quality diagnostic imaging beyond traditional hospital settings. The solutions feature Rayence's SHINE denoising algorithm for clear images at low radiation doses and military-grade detector durability, aiming to enhance diagnostic efficiency in emergency, disaster relief, and remote healthcare scenarios. This development is expected to accelerate the expansion of telemedicine and mobile healthcare globally, particularly in environments with limited conventional imaging infrastructure. Rayence anticipates these products will set a new standard for point-of-care diagnostics and strengthen its leadership in medical and veterinary imaging markets.
Rayence's launch of its Anywhere-M and Anywhere-V portable X-ray solutions signifies a notable advancement in point-of-care diagnostics, with significant implications for Asia's healthcare technology landscape. The integrated, all-in-one design, combining generator, detector, and software, addresses critical needs for rapid, high-quality imaging in remote, emergency, and field settings. This is particularly relevant for diverse Asian geographies, where access to advanced medical infrastructure can be uneven. The focus on durability and the SHINE denoising algorithm, which improves image quality at lower radiation doses, makes these solutions well-suited for challenging environments and aligns with growing demands for efficient, patient-centric care. The veterinary application, Anywhere-V, also opens new avenues for animal healthcare across the region, from livestock farms to wildlife rescue centers.
This development underscores a broader trend in the Asian tech ecosystem towards decentralizing healthcare services and leveraging technology to bridge geographical and infrastructural gaps. As telemedicine and mobile healthcare gain traction, especially post-pandemic, integrated diagnostic tools like Rayence's become crucial enablers. The cost-effectiveness and high performance of these solutions could accelerate their adoption in developing Asian markets, fostering a more resilient and accessible healthcare infrastructure. Furthermore, Rayence's strategic positioning to strengthen its leadership in the US market, while being a South Korean firm, highlights the increasing global competitiveness and innovation coming from Asian medical technology companies.
Related reading
6 storiesDrones Market Surges with 10.2% CAGR During 2026–2035, Fueled by Rising Commercial Drone Adoption
Our market analysis shows how advanced portable tech, like these X-ray solutions, is driving growth in related sectors.

HSBC Gives Wealthy Singapore Clients Access to Private Markets

OpenAI said to explore pre-IPO funding at $1.2T valuation

Samsung Starts Trial Production of Tesla AI Chips in Texas

Amodei and Huang Spar Over AI Rules at Dreamforce, Extending Industry Rift

